AU2004303737A1 - Nicotinic acetylcholine receptor ligands - Google Patents
Nicotinic acetylcholine receptor ligands Download PDFInfo
- Publication number
- AU2004303737A1 AU2004303737A1 AU2004303737A AU2004303737A AU2004303737A1 AU 2004303737 A1 AU2004303737 A1 AU 2004303737A1 AU 2004303737 A AU2004303737 A AU 2004303737A AU 2004303737 A AU2004303737 A AU 2004303737A AU 2004303737 A1 AU2004303737 A1 AU 2004303737A1
- Authority
- AU
- Australia
- Prior art keywords
- disease
- atoms
- sulfur
- oxygen
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53171203P | 2003-12-22 | 2003-12-22 | |
| US60/531,712 | 2003-12-22 | ||
| PCT/SE2004/001940 WO2005061494A1 (en) | 2003-12-22 | 2004-12-20 | Nicotinic acetylcholine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2004303737A1 true AU2004303737A1 (en) | 2005-07-07 |
Family
ID=34710246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004303737A Abandoned AU2004303737A1 (en) | 2003-12-22 | 2004-12-20 | Nicotinic acetylcholine receptor ligands |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070270458A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1699786A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007515478A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060125812A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1914201A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004303737A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417927A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2550844A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL176071A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06007026A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20063356L (cg-RX-API-DMAC7.html) |
| SG (1) | SG149052A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005061494A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200605074B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2582339C2 (ru) | 2010-05-27 | 2016-04-27 | Таргасепт, Инк. | Неконкурентные антагонисты никотиновых рецепторов |
| EP2593447B1 (de) | 2010-07-15 | 2016-08-17 | Bayer Intellectual Property GmbH | 3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel |
| CA3169697A1 (en) * | 2020-02-28 | 2021-09-02 | Dominic Reynolds | Thiophenyl derivatives useful for modulating nucleic acid splicing |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2529548A1 (fr) * | 1982-07-02 | 1984-01-06 | Delalande Sa | Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique |
| EP0287196B1 (en) * | 1987-02-18 | 1994-11-23 | Beecham Group Plc | Indole derivatives, process for their preparation and pharmaceutical compositions containing them |
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| WO2002015662A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| WO2002017358A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| JP2004506734A (ja) * | 2000-08-21 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用のキヌクリド置換ヘテロアリール部分 |
| DE10156719A1 (de) * | 2001-11-19 | 2003-05-28 | Bayer Ag | Heteroarylcarbonsäureamide |
-
2004
- 2004-12-20 MX MXPA06007026A patent/MXPA06007026A/es unknown
- 2004-12-20 JP JP2006546908A patent/JP2007515478A/ja not_active Abandoned
- 2004-12-20 AU AU2004303737A patent/AU2004303737A1/en not_active Abandoned
- 2004-12-20 US US10/583,582 patent/US20070270458A1/en not_active Abandoned
- 2004-12-20 WO PCT/SE2004/001940 patent/WO2005061494A1/en not_active Ceased
- 2004-12-20 BR BRPI0417927-7A patent/BRPI0417927A/pt not_active IP Right Cessation
- 2004-12-20 SG SG200809495-5A patent/SG149052A1/en unknown
- 2004-12-20 CA CA002550844A patent/CA2550844A1/en not_active Abandoned
- 2004-12-20 CN CNA2004800412932A patent/CN1914201A/zh active Pending
- 2004-12-20 KR KR1020067012361A patent/KR20060125812A/ko not_active Withdrawn
- 2004-12-20 EP EP04809113A patent/EP1699786A1/en not_active Withdrawn
-
2006
- 2006-05-31 IL IL176071A patent/IL176071A0/en unknown
- 2006-06-20 ZA ZA200605074A patent/ZA200605074B/en unknown
- 2006-07-19 NO NO20063356A patent/NO20063356L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200605074B (en) | 2007-05-30 |
| SG149052A1 (en) | 2009-01-29 |
| WO2005061494A1 (en) | 2005-07-07 |
| US20070270458A1 (en) | 2007-11-22 |
| MXPA06007026A (es) | 2006-08-31 |
| KR20060125812A (ko) | 2006-12-06 |
| CA2550844A1 (en) | 2005-07-07 |
| BRPI0417927A (pt) | 2007-04-17 |
| EP1699786A1 (en) | 2006-09-13 |
| IL176071A0 (en) | 2006-10-05 |
| NO20063356L (no) | 2006-09-21 |
| JP2007515478A (ja) | 2007-06-14 |
| CN1914201A (zh) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005233492B2 (en) | Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor | |
| EP1699801A1 (en) | Nicotinic acetylcholine receptor ligands | |
| US20070191422A1 (en) | Nicotinic acetylcholine receptor ligands | |
| US20070270458A1 (en) | Nicotinic Acetylcholine Receptor Ligands | |
| CN100445285C (zh) | 烟碱性乙酰胆碱受体配体 | |
| US7384954B2 (en) | 4-substituted imidazoles | |
| AU2004291456A1 (en) | 5-substituted imidazoles | |
| WO2005030777A1 (en) | Non-amide nonanes | |
| MXPA06011725A (en) | Novel 2-(1-aza-bicyclo [2.2.2]oct-3-yl) -2, 3-dihydroisoindol -l-one/5, 6-dihydro-furo[2, 3-c]pyrrol -4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor | |
| MXPA06005416A (en) | 4-substituted imidazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |